HRT and selective estrogen-receptor modulators should not be used for the prevention of cardiovascular disease (CVD) [108]; if prescribed, it must remain a short-term solution, using the lowest dose possible to minimize night sweats, the systemic use being reserved for disabling night sweats and hot flashes and not for long term primary and secondary CVD prevention [109]. This evidence concerns the gene ESR1 and cardiovascular disorder.